Product Information
ALREX 0.2% EYE DROPS is a brand product labeled by Bausch & Lomb Incorporated, priced at $58.0305 per ML under NDC 24208035305. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Mar 9, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the loteprednol etabonate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2 mg/mL
Manufacturer
Bausch & Lomb IncorporatedNDC
24208035305
Classification
Brand
Dosage Form
SUSPENSION/ DROPS
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
LOTEPREDNOL ETABONATEApproval Type
New Drug (NDA)
FDA Application
NDA020803FDA Approved
3/9/1998
TE Code
AB
On Market Since
3/9/1998
Pharmacological Classes
Price Statistics
The NADAC for ALREX 0.2% EYE DROPS has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 114.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $58.0305 per ML |
|---|---|
| All-time high | $58.2085 (May 14, 2025) |
| All-time low | $27.0880 (Nov 28, 2013) |
| 52-week high | $58.0341 |
| 52-week low | $57.9234 |
| Median price | $45.8316 |
| Average price | $45.2067 |
| Largest weekly change | +10.0% (Jan 14, 2015) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 44% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ALREX 0.2% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for ALREX 0.2% EYE DROPS, manufactured by Bausch & Lomb Incorporated, is $58.0305 per ML (NDC 24208035305), effective Aug 19, 2026.
How has the price of ALREX 0.2% EYE DROPS changed over time?
Over the history we have for it, the NADAC for ALREX 0.2% EYE DROPS has risen 114.2%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ALREX 0.2% EYE DROPS?
Since Nov 28, 2013, the NADAC for ALREX 0.2% EYE DROPS has ranged from a low of $27.0880 (Nov 28, 2013) to a high of $58.2085 (May 14, 2025), with a median of $45.8316 per ML.
Are there cheaper alternatives to ALREX 0.2% EYE DROPS?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LOTEPREDNOL ETABONATE 0.2% DRP, is $32.2996 per ML — about 44% below ALREX 0.2% EYE DROPS.
Who manufactures ALREX 0.2% EYE DROPS?
ALREX 0.2% EYE DROPS (NDC 24208035305) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a brand product.